Skip to main content
  • Home
  • About
  • Faculty Experts
  • For The Media
  • ’Cuse Conversations Podcast
  • Topics
    • Alumni
    • Events
    • Faculty
    • Students
    • All Topics
  • Contact
  • Submit
STEM
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
Sections
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
  • Home
  • About
  • Faculty Experts
  • For The Media
  • ’Cuse Conversations Podcast
  • Topics
    • Alumni
    • Events
    • Faculty
    • Students
    • All Topics
  • Contact
  • Submit
STEM

Researchers Close to Understanding Disease Mechanisms of ALS

Thursday, March 8, 2018, By Rob Enslin
Share
BioInspiredCollege of Arts and SciencesfacultyResearch and CreativeSTEM

Researchers in the College of Arts and Sciences (A&S) are making strides in understanding the disease mechanism of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

Carlos Castañeda

Carlos Castañeda

Carlos A. Castañeda, assistant professor of biology, chemistry and interdisciplinary neuroscience, and Thuy Dao, a postdoctoral researcher in chemistry, have been working with ubiquitin, a tiny molecule that tags obsolete proteins in a cell. They recently found that ubiquitin eliminates droplets of Ubiquilin-2 (UBQLN2) in solution.

The discovery is noteworthy, Castañeda says, because UBQLN2 is a protein-encoding gene, mutations to which cause ALS and various types of dementia, such as frontotemporal dementia (FTD).

“UBQLN2 is found in motor neuron inclusions of patients with ALS,” he says. “We show that UBQLN2 undergoes liquid-liquid phase separation, in which proteins coalesce into protein-rich droplets to form membraneless organelles in cells. Interestingly, dysfunction of membraneless organelle assembly and disassembly is emerging as a common pathogenic mechanism of ALS and other neurodegenerative disorders.”

Other authors include Brian Martyniak G’18, a second-year Ph.D. student in chemistry and biochemistry, who belongs to Castañeda’s lab; members of J. Paul Taylor’s research group from both St. Jude Children’s Research Hospital and the Howard Hughes Medical Institute; and members of Heidi Hehnly’s lab at SUNY Upstate Medical University.

“We want to understand the mechanisms that trigger motor neurons to degenerate in ALS,” says Castañeda, the paper’s lead contact. “It appears that pathological stress granules—membraneless organelles thought to be formed by liquid-liquid phase separation of RNA-binding proteins—trigger ALS and related disorders, leading to cell death.”

Three people in lab coats looking at computer

From left, Castañeda, Brian Martyniak G’18 and Thuy Dao

Scientists know that when a eukaryotic cell is under stress, it causes certain proteins and RNA to form stress granules (SGs). While this is normal behavior, persistence of SGs or dysregulation of SG dynamics can promote disease states. Castañeda and Dao, in collaboration with Taylor’s group, showed that UBQLN2 was “recruited” to SGs. “This gives our work potential ALS relevance, since mutations in UBQLN2 might lead to defects in either SG assembly, or SG disassembly, or both,” Castañeda says.

There are billions of neurons, or nerve cells, in the nervous system. (The brain alone has more than 100 billion of them.) When ALS attacks neurons, their corresponding muscles weaken and die. People with ALS eventually lose the ability to speak, eat, move or breathe.

Castañeda, who studies proteins associated with neurodegenerative and neuromuscular disease, explains that muscle weakness or stiffness is usually the first sign of ALS: “It is followed by atrophy and paralysis of the muscles of the limbs and trunk, and of the muscles controlling vital functions. The average survival time is three years after diagnosis.”

Ubiquitin and UBQLN2 are part of what of Castañeda calls a “quality-control mechanism,” which maintains proteins at their proper levels during the lifespan of a cell. (Unlike other cells, which live several days or weeks, neurons typically last an entire lifetime.) Any kind of disruption to protein homeostasis usually impairs neuronal development and function.

“We postulated—and eventually confirmed with microscopy and nuclear magnetic resonance spectroscopy—that ubiquitin disrupts UBQLN2 liquid-liquid phase separation,” says Castañeda, who joined Syracuse’s faculty in 2014. “This was significant because ubiquitin tags many proteins, at one point or another.”

Castañeda ultimately hopes to redirect UBQLN2 out the “ubiquinated” substrates in SGs and into protein quality-control pathways. “UBQLN2 is like a shuttle, ferrying misfolded proteins to the cell’s protein-recycling plant,” he continues. “Under normal conditions, SGs dissipate when the stress condition is removed. However, if the condition impairs SG assembly in any way, ALS-linked RNA-binding proteins begin to aggregate.”

Graphic of nerve cells and how ALS progresses

Courtesy of the ALS Foundation for Life

While there is no cure for ALS, many people with the disease live longer, thanks to clinical management and two FDA-approved drugs: riluzole and radicava.

Castañeda is optimistic his innovative work with ubiquitin and UBQLN2 will achieve a greater understanding of ALS’ molecular mechanisms and lead to a cure. “UBQLN2 interacts with other RNA-binding proteins, including TDP-43, which is found in 97 percent of inclusions of patients diagnosed with familial or sporadic ALS,” he says. “I look forward to investigating these interactions.”

Studies show that most people who develop ALS are between the ages of 40 and 70, with the disease being 20 percent more common in men. Although scientists struggle to determine the specific genetics or environmental factors that trigger ALS, they find that military veterans, particularly those deployed in the Gulf War from 1990-91, are twice as likely to develop the disease.

“Defects in protein recycling contribute to neurodegeneration,” Castañeda says. “The more we understand UBQLN2’s biological functions—specifically, how its mutations lead to ALS—the better able we can develop new therapies.”

The ALS Association is the only national nonprofit organization fighting Lou Gehrig’s Disease on every front. By leading the way in global research, providing assistance for people with ALS through a nationwide network of chapters, coordinating multidisciplinary care through certified clinical care centers and fostering government partnerships, the association builds hope and enhances quality of life while aggressively searching for new treatments and a cure.

  • Author

Rob Enslin

  • Recent
  • College of Visual and Performing Arts Welcomes New Full-Time Faculty
    Monday, September 25, 2023, By Erica Blust
  • School of Education Faculty Publish ‘Lesson Study With Mathematics and Science Preservice Teachers’
    Sunday, September 24, 2023, By Martin Walls
  • Water Main Break Near Bird Library to Be Repaired Monday
    Sunday, September 24, 2023, By News Staff
  • University Musicians, West Point Band to Perform Together This Weekend As Part of Events Around Military Appreciation Day
    Friday, September 22, 2023, By Christine Weber
  • Turning Young Enthusiasts Into Scientific Researchers
    Friday, September 22, 2023, By Wendy S. Loughlin

More In STEM

Turning Young Enthusiasts Into Scientific Researchers

Miguel Guzman ’24, a native of Lima, Peru, is a senior biotechnology major in the College of Arts and Sciences with an entrepreneurship and emerging enterprises minor in the Whitman School of Management. His research centers on developing bio-enabled protein…

Center for Sustainable Community Solutions and Environmental Finance Center Announces New Director

The College of Engineering and Computer Science is pleased to announce the transition of Melissa Young into a new role as director of the Center for Sustainable Community Solutions-Environmental Finance Center (CSCS-EFC) at Syracuse University. CSCS-EFC is housed within the…

Civil and Environmental Engineering Professor Attends UN Session on Reducing Plastic Pollution

Civil and Environmental Engineering Professor Svetoslava Todorova attended the second session of the United Nations (UN) Intergovernmental Negotiations Committee on Plastics this summer in Paris, France. Todorova was invited as an academic expert based on her research on the environment,…

Experts Say Federal Agency or Global Organization Should Govern AI, New Survey Co-sponsored by Two University Institutes Finds

A new survey co-sponsored by two Syracuse University institutes finds that a majority of computer science experts at top U.S research universities want to see the creation of a new federal agency or global organization to govern artificial intelligence (AI)….

Q&A With School of Information Studies Dean Andrew Sears: Seeing Countless Opportunities in the Ever-Changing Tech World

In the rapidly changing world of technology, School of Information Studies Dean Andrew Sears knows it’s hard to predict how technology and the iSchool will evolve if you look too far into the future. But, he knows if you pay…

Subscribe to SU Today

If you need help with your subscription, contact sunews@syr.edu.

Connect With Us

  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
Social Media Directory

For the Media

Find an Expert Follow @SyracuseUNews
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • @SyracuseU
  • @SyracuseUNews
  • @SUCampus
  • Social Media Directory
  • Accessibility
  • Privacy
  • Campus Status
  • Syracuse.edu
© 2023 Syracuse University News. All Rights Reserved.